(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 66.64%3.34B | 94.95%1.61B | 66.86%2.01B | 14.50%826.95M | 36.30%1.2B | 121.61%722.2M | 4.83%882.33M | -3.22%325.9M | 6.02%841.65M | 125.71%336.76M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -49.02%-105.42M | -74.27%-51.43M | 14.55%-70.74M | 12.20%-29.51M | 26.61%-82.78M | 41.31%-33.61M | -120.48%-112.79M | -219.75%-57.28M | -125.99%-51.16M | -60.09%-17.91M |
Attributable subsidiary (profit) loss | -175.66%-143K | ---165K | --189K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | 420.97%35.66M | 42.32%24.88M | -103.72%-11.11M | -83.44%17.49M | 319.48%298.56M | 2,908.67%105.58M | 670.04%71.18M | -143.85%-3.76M | -41.70%9.24M | 188.40%8.57M |
-Impairment of property, plant and equipment (reversal) | -356.60%-5.56M | ---- | --2.17M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | 2,866.69%43.19M | ---- | -177.93%-1.56M | ---- | -61.94%2M | ---- | -40.36%5.26M | -316.15%-5.75M | --8.83M | ---1.38M |
-Other impairments and provisions | 83.26%-1.96M | 42.32%24.88M | -103.95%-11.72M | -83.44%17.49M | 349.93%296.56M | 5,210.76%105.58M | 15,668.42%65.91M | -80.03%1.99M | -97.36%418K | 202.64%9.95M |
Revaluation surplus: | 132.86%12.4M | -19,697.08%-60.98M | -364.66%-37.73M | -104.75%-308K | -102.56%-8.12M | -97.17%6.49M | 77.35%317.75M | 460.19%229.32M | 236.21%179.17M | -87.96%40.94M |
-Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -27.22%69.05M | 57.46%93.33M |
-Derivative financial instruments fair value (increase) | 132.86%12.4M | -7,767.21%-24.23M | -364.66%-37.73M | -104.43%-308K | -102.56%-8.12M | -96.97%6.96M | 188.56%317.75M | 537.66%229.32M | 148.64%110.12M | -118.67%-52.4M |
-Other fair value changes | ---- | ---36.74M | ---- | ---- | ---- | ---470K | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | -408.32%-69.05M | -16.87%2.33M | -511.48%-13.58M | -83.57%2.8M | 107.58%3.3M | 145.30%17.06M | 76.60%-43.54M | -378.39%-37.66M | -730.00%-186.03M | 1,768.23%13.53M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---200.45M | ---- |
-Loss (gain) on sale of property, machinery and equipment | -15.65%3.7M | -16.87%2.33M | 32.99%4.39M | -83.57%2.8M | 107.58%3.3M | 145.30%17.06M | -402.10%-43.54M | -378.39%-37.66M | -51.20%14.41M | 1,768.23%13.53M |
-Loss (gain) from selling other assets | -304.76%-72.75M | ---- | ---17.97M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | 2.39%565.65M | 3.65%302.9M | -11.02%552.43M | -3.31%292.24M | 1.04%620.86M | -0.20%302.26M | -9.07%614.47M | -1.15%302.85M | -9.62%675.73M | -12.98%306.39M |
-Amortization of intangible assets | -10.47%17.45M | 3.35%8.77M | 17.27%19.49M | 33.74%8.48M | 30.73%16.62M | 2.70%6.34M | 0.83%12.71M | 2.25%6.18M | 2.63%12.61M | -14.44%6.04M |
Financial expense | -18.01%66.9M | 77.67%38.74M | 35.47%81.6M | -32.63%21.8M | -66.77%60.23M | -74.53%32.36M | -35.45%181.27M | -7.91%127.05M | 13.75%280.84M | 9.38%137.96M |
Unrealized exchange loss (gain) | -122.26%-10.97M | -118.49%-13.23M | 179.41%49.3M | 402.70%71.52M | 39.28%-62.08M | -749.42%-23.63M | -282.01%-102.24M | 135.68%3.64M | -48.55%56.17M | -128.94%-10.2M |
Special items | -47.23%32.05M | 349.41%53.56M | 1,025.65%60.73M | 250.16%11.92M | 138.04%5.4M | -47.40%-7.94M | -5.22%-14.18M | -14.94%-5.38M | 42.84%-13.48M | 77.45%-4.68M |
Operating profit before the change of operating capital | 47.88%3.87B | 57.11%1.91B | 28.45%2.62B | 8.40%1.21B | 13.59%2.04B | 26.69%1.12B | 0.12%1.79B | 9.04%884.68M | 1.53%1.79B | -15.63%811.34M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 25.30%-118.05M | 84.52%-33.3M | 72.64%-158.04M | 2.81%-215.18M | -508.23%-577.53M | -634.50%-221.4M | 218.49%141.47M | 171.42%41.42M | 57.93%-119.4M | 70.85%-57.99M |
Accounts receivable (increase)decrease | -298.30%-1.56B | -422.88%-1.12B | 54.41%-392.22M | 42.64%-214.7M | -71.90%-860.37M | ---374.28M | -269.65%-500.5M | ---- | 145.79%295.02M | 91.34%-18.21M |
Accounts payable increase (decrease) | 232.42%792.37M | 1,749.41%747.96M | -79.27%238.36M | -91.87%40.44M | 328.53%1.15B | 304.80%497.48M | 30,805.76%268.26M | -236.11%-242.91M | -99.85%868K | 17.10%178.46M |
prepayments (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --102.24M | ---- | ---- |
Special items for working capital changes | -169.18%-16.9M | -63.37%-30.64M | -18.10%24.43M | -178.34%-18.76M | 62.19%29.83M | -216.55%-6.74M | 311.26%18.39M | 157.02%5.78M | 53.23%-8.71M | -121.48%-10.14M |
Cash from business operations | 27.29%2.97B | 82.24%1.47B | 30.96%2.33B | -20.59%806.71M | 3.35%1.78B | 28.39%1.02B | -12.15%1.72B | -12.42%791.22M | 39.58%1.96B | 20.14%903.46M |
Other taxs | -75.75%-526.99M | -85.30%-272.68M | -26.54%-299.85M | 1.71%-147.16M | -53.83%-236.97M | -37.02%-149.71M | 2.95%-154.05M | -6.14%-109.26M | 16.85%-158.74M | 40.80%-102.95M |
Net cash from operations | 20.14%2.44B | 81.56%1.2B | 31.64%2.03B | -23.85%659.55M | -1.61%1.54B | 27.00%866.11M | -12.96%1.57B | -14.81%681.96M | 48.46%1.8B | 38.48%800.51M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 49.02%105.42M | 74.27%51.43M | 37.10%70.74M | 76.58%29.51M | 25.55%51.59M | -17.39%16.71M | -19.67%41.09M | 12.94%20.23M | 125.99%51.16M | 60.09%17.91M |
Decrease in deposits (increase) | -309.18%-277.55M | -89.21%20.35M | 134.27%132.69M | 221.55%188.54M | -232.47%-387.2M | -171.80%-155.12M | 289.81%292.28M | 256.73%216.05M | -841.30%-153.99M | -217.71%-137.85M |
Sale of fixed assets | -42.43%4.37M | 792.06%2.25M | -60.42%7.59M | -91.95%252K | -68.84%19.16M | -93.01%3.13M | 733.33%61.5M | 6,132.31%44.75M | -76.92%7.38M | 111.18%718K |
Purchase of fixed assets | -63.21%-1.14B | -60.12%-396.7M | -66.82%-701.07M | 19.47%-247.75M | 18.39%-420.25M | -146.36%-307.65M | -37.34%-514.98M | 16.69%-124.88M | 21.48%-374.98M | -49.60%-149.9M |
Purchase of intangible assets | -381.74%-187.45M | 98.06%-495K | -653.51%-38.91M | -1,039.48%-25.51M | 24.23%-5.16M | ---2.24M | 61.06%-6.82M | ---- | 15.79%-17.5M | -1,238.44%-9.26M |
Recovery of cash from investments | 43.26%2.44B | --3.2B | --1.7B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | -41.02%-2.5B | -4,521.73%-3.26B | -2,758.63%-1.77B | -70.20%-70.57M | -292.50%-61.92M | 19.16%-41.46M | 72.04%-15.78M | -506.15%-51.29M | 0.35%-56.43M | 92.24%-8.46M |
Other items in the investment business | ---- | ---- | -99.12%1.91M | ---- | -30.02%216.55M | 17.90%118.03M | 178.51%309.45M | --100.11M | 733.67%111.11M | ---- |
Net cash from investment operations | -161.71%-1.56B | -203.96%-381.56M | -1.31%-594.92M | 65.95%-125.53M | -452.14%-587.22M | -279.83%-368.6M | 138.49%166.76M | 171.46%204.97M | 13.94%-433.25M | -18.62%-286.84M |
Net cash before financing | -38.53%882.49M | 52.79%815.91M | 50.28%1.44B | 7.34%534.03M | -44.92%955.33M | -43.91%497.51M | 26.80%1.73B | 72.67%886.93M | 92.71%1.37B | 52.76%513.67M |
Cash flow from financing activities | ||||||||||
New borrowing | -30.75%2.04B | 44.42%1.24B | 111.70%2.95B | 52.57%861.36M | -42.05%1.39B | -74.98%564.56M | -35.53%2.41B | 28.42%2.26B | 290.52%3.73B | 192.16%1.76B |
Refund | -5.91%-2.78B | -221.59%-2.03B | -53.50%-2.62B | -26.53%-631.36M | 57.91%-1.71B | 84.11%-498.97M | -36.04%-4.06B | -197.67%-3.14B | -147.76%-2.99B | -41.78%-1.06B |
Interest paid - financing | -3.72%-78.43M | -138.93%-40.64M | -49.86%-75.62M | 49.28%-17.01M | 59.36%-50.46M | 63.58%-33.53M | 42.45%-124.16M | -7.64%-92.07M | -5.98%-215.75M | 1.53%-85.54M |
Dividends paid - financing | -113.27%-581.45M | ---- | -23.45%-272.64M | ---- | -72.35%-220.85M | ---- | -30.25%-128.14M | ---- | -16.51%-98.38M | ---- |
Absorb investment income | 500.00%12M | ---- | --2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | -2.80%-42.29M | ---40.69M | ---41.14M | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | -39.91%24.13M | 900.84%14.26M | 329.15%40.16M | --1.43M | 551.74%9.36M | ---- | --1.44M | ---- | ---- | ---- |
Net cash from financing operations | -5,538.82%-1.36B | -574.38%-814.74M | 96.11%-24.17M | 450.88%171.75M | 67.45%-620.93M | 103.19%31.18M | -700.38%-1.91B | -282.83%-976.62M | 138.63%317.73M | 247.04%534.17M |
Effect of rate | -247.68%-892K | -49.15%597K | 411.34%604K | 75.22%1.17M | -103.88%-194K | 20.29%670K | 282.04%5M | -23.91%557K | -460.24%-2.75M | 130.63%732K |
Net Cash | -134.02%-480.19M | -99.83%1.17M | 322.09%1.41B | 33.50%705.77M | 293.28%334.4M | 689.42%528.69M | -110.26%-173.01M | -108.56%-89.7M | 1,596.59%1.69B | 3,979.16%1.05B |
Begining period cash | 42.39%4.74B | 42.39%4.74B | 11.15%3.33B | 11.15%3.33B | -5.31%3B | -5.31%3B | 113.57%3.16B | 113.57%3.16B | -7.02%1.48B | -7.02%1.48B |
Cash at the end | -10.14%4.26B | 17.51%4.74B | 42.39%4.74B | 14.51%4.04B | 11.15%3.33B | 14.65%3.53B | -5.31%3B | 21.55%3.08B | 113.57%3.16B | 61.76%2.53B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data